HK Stock Market Move | Asymchem Laboratories (06821) rises over 4%, plans to repurchase no less than RMB500 million of A-shares; the company's emerging businesses continue to ramp up volume.

Asymchem Laboratories (06821) rose over 4%, up 4.62% as of press time at HK$126.9, with turnover of HK$189 million. On the news front, on November 4, Asymchem Laboratories announced a plan to repurchase A-shares, which will be used for the subsequent implementation of an employee stock ownership plan or equity incentive and for cancellation to reduce registered capital. The repurchase funds will be no less than RMB500 million and no more than RMB700 million. The repurchase price will not exceed RMB246 per share, and the final total repurchase amount will be based on the actual funds used. Previously, Asymchem Laboratories reported its results for the first three quarters of 2026, with operating revenue of approximately RMB5.395 billion, up 16.52% year on year; net profit attributable to shareholders of the listed company of approximately RMB852 million, up 6.49% year on year. A research report from Shenwan Hongyuan Group noted that Asymchem Laboratories' emerging business revenue in the first three quarters was RMB1.923 billion, up 50.20% year on year, with strong growth in chemical macromolecules, biological macromolecules and formulation businesses. The company's newly signed orders in 2026Q3 maintained double-digit year-on-year growth, and delivery scale in the fourth quarter is expected to increase significantly compared with the third quarter. The company maintains its full-year operating revenue growth guidance of 19%-22%.